C

The Cooper Companies, Inc. COO

$61.60 $2.634.45% NASDAQ
Recommendation
Dividend Power Score
Day's Range
$59.27$61.63
Latest Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
P/E (TTM)
EPS (TTM)
Access our Premium Ratings
Get Access

COO Rating

Reward
Risk

COO Rating Factors

Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Yield Index

COO Company Overview

The Cooper Companies, Inc. is a global medical device company focused on vision care and women’s health. The company operates primarily through two business units: CooperVision and CooperSurgical. CooperVision develops and manufactures contact lenses, including toric, multifocal, spherical, and myopia management lenses, while CooperSurgical provides fertility, reproductive health, and gynecological medical devices and services. The company operates within the broader healthcare, medical technology, and specialty medical products industries, with revenue driven largely by recurring demand for disposable contact lenses and fertility-related products and procedures.

The company serves eye care professionals, fertility clinics, hospitals, surgical centers, and healthcare providers across developed and emerging markets. A key strategic advantage is its diversified exposure to both vision care and women’s health, including strong positions in specialty contact lenses and fertility treatment technologies. Founded in 1958, Cooper evolved from a diversified healthcare holding company into a focused medical technology enterprise through acquisitions, divestitures, and expansion into global healthcare markets. The company significantly expanded its women’s health business through acquisitions including Origio, LifeGlobal, and Generate Life Sciences, while continuing to build scale in contact lenses through manufacturing and product innovation.

Data compiled by narrative technology. May contain errors.
Sector

COO Income Statement

Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)

COO Balance Sheet

Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)

COO Cash Flow

Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)

COO Price History

Loading...
52-Week Range27% of range
Current
$61.60
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return

COO Valuation

Market Cap
Market Cap Rank
#2,268
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)

COO Dividends and Shares

Shares Outstanding
Dividend Per Share (Most Recent)
Dividend Per Share (TTM)
--

COO Corporate Info

Phone Number
925 460 3600
Address
6101 Bollinger Canyon Road
Suite 500
San Ramon, CA 94583
Country
Year Founded

COO Filings

Filing Date
Wednesday, September 9, 2026
Period Date
Tuesday, June 30, 2026
Next Filing
Beginning of December (est)

COO Headlines